The company said it would seek emergency use approval early next month for its one-shot coronavirus vaccine after results from a late-stage study showed it provided strong protection against COVID-19. Continue reading →
The new Johnson & Johnson vaccine was hailed as good news, even though the company reported its one-shot dose had a lower efficacy rate than its two-shot rivals. Here's why. Continue reading →
The overriding concern is that the alarming speed of the spread will allow the virus to evolve in more insidious ways that could defy the protections of existing vaccines, epidemiologists say. Continue reading →
Primary care doctors, long the mainstay of vaccination campaigns, say they’ve been left out and in the dark when it comes to battling the coronavirus. Yet they believe their involvement is essential to counter the misinformation that could undermine the whole effort. Continue reading →
The company said it would seek emergency use approval early next month for its one-shot coronavirus vaccine after results from a late-stage study showed it provided strong protection against COVID-19. Continue reading →
Malley will be responsible for trying to persuade Iran to rein in its nuclear program and agree to new negotiations before the United States lifts its bruising economic sanction. Continue reading →
The European Union’s regulator recommended authorization of the Oxford-AstraZeneca coronavirus vaccine for use in the 27-country bloc on Friday, despite a lack of data about efficacy in older people. Continue reading →
US airstrikes in a joint mission with Iraqi forces have killed the top Islamic State group leader in Iraq, an attack aimed at stemming the group’s resurgence and exacting retribution for a deadly double-suicide bombing in Baghdad last week. Continue reading →
Members of a World Health Organization team investigating the origins of the coronavirus pandemic visited another Wuhan hospital that had treated early COVID-19 patients on their second full day of work on Saturday. Continue reading →
After decades of failing to recognize the Supreme Court as a crucial election issue, as Republicans have, Democrats seem to see the light. Continue reading →
A section of the baseball stadium concourse has been converted into a mass vaccination site, and next week it will open for people eligible to receive the shots. Continue reading →
Primary care doctors, long the mainstay of vaccination campaigns, say they’ve been left out and in the dark when it comes to battling the coronavirus. Yet they believe their involvement is essential to counter the misinformation that could undermine the whole effort. Continue reading →
A section of the baseball stadium concourse has been converted into a mass vaccination site, and next week it will open for people eligible to receive the shots. Continue reading →
Senator Elizabeth Warren is continuing to voice concern over the GameStop stock saga, but she said she thinks the root of the issue is broader than a handful of manipulated stock prices. Continue reading →
Keith Gill is a 34-year-old former employee of MassMutual who, on the Internet chat site Reddit and through YouTube videos, has been pounding the table on behalf of the beleaguered video game retailer since 2019. Continue reading →
Jonas Gwangwa, a preeminent South African trombonist, vocalist, and composer who became a leading artistic ambassador for the anti-apartheid resistance, died Sunday. He was 83. Continue reading →
Blind from birth, Pauline Anna Strom found in synthesizers a way to create compositions that reflected her complex internal landscape, one that was not confined to the present but roamed freely through time and emotions. Continue reading →
Mr. Smith’s bold clothing choices matched his reporting style: authentic, fair and unafraid, said Michael Lee, a sports reporter for The Washington Post who met Mr. Smith almost 22 years ago. While he was tough on teams, they knew it was always merited, Lee said. Continue reading →
You received this message because you signed up for the Today's headlines newsletter. To automatically unsubscribe, please click here.
Please note: this will unsubscribe you from the newsletter only. If you wish to cancel your BostonGlobe.com subscription, please call 1-888-MY-GLOBE (1-888-694-5623).
